| Application no. and date | 16751123.7 (espacenet) (Federated) (European Patent Register), 20160805 | | Patent/reg. no. and date | DK/EP 3334721, 20210428 | | Publication date | 20180620 | | Priority no. and date | US 201562203996 P, 20150812, US 201562266867 P, 20151214 | | EP pub. no. and date |
EP 3334721 20180620 | | Effective date | | | Applicant/owner | Eli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US | | Applicant ref. no. | V53101DK00 | | Inventor | COATES, David Andrew, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, IN 46206-6288, US,
FORTNER, Kevin Charles, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, IN 46206-6288, US,
MASSEY, Steven Marc, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, IN 46206-6288, US,
MYERS, Jason Kenneth, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, IN 46206-6288, US,
NAVARRO, Antonio, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, IN 46206-6288, US,
SIEGEL, Miles Goodman, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, IN 46206-6288, US,
STUCKY, Russell Dean, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, IN 46206-6288, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/4439 (2006.01) , A61P 25/06 (2006.01) , C07D 401/12 (2006.01) | | Title | CGRP-RECEPTORANTAGONISTER | | Int. application no. | US2016045698 | | Int. publication no. | WO2017027345 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
